L-705302

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-705302
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5-lipoxygenase activating protein inhibitorsLeukotriene inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseLeukotriene5-lipoxygenase activating protein
Therapy Area/IndicationsAsthmaInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Frosst Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Frosst Company
Active IndicationsN/A
Inactive IndicationsAsthmaInflammatory Bowel DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A